Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 353


RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-κB Signaling and MMP1 Expression.

Ming XY, Zhang X, Cao TT, Zhang LY, Qi JL, Kam NW, Tang XM, Cui YZ, Zhang BZ, Li Y, Qin YR, Guan XY.

Theranostics. 2018 Jan 1;8(1):185-198. doi: 10.7150/thno.21383. eCollection 2018.


Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma.

Dai Y, Liu L, Zeng T, Liang JZ, Song Y, Chen K, Li Y, Chen L, Zhu YH, Li J, Li Y, Xie D, Yuan YF, Guan XY.

Am J Pathol. 2018 Feb;188(2):378-391. doi: 10.1016/j.ajpath.2017.10.016. Epub 2017 Nov 22.


AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways.

Chow RKK, Tsz-Kwan Sin S, Liu M, Li Y, Man Chan TH, Song Y, Chen L, Lai-Wan Kwong D, Guan XY.

Oncotarget. 2016 Oct 18;8(48):83469-83479. doi: 10.18632/oncotarget.12726. eCollection 2017 Oct 13.


The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma.

Zhong Q, Liu ZH, Lin ZR, Hu ZD, Yuan L, Liu YM, Zhou AJ, Xu LH, Hu LJ, Wang ZF, Guan XY, Hao JJ, Lui VWY, Guo L, Mai HQ, Chen MY, Han F, Xia YF, Grandis JR, Zhang X, Zeng MS.

Clin Cancer Res. 2018 Feb 1;24(3):659-673. doi: 10.1158/1078-0432.CCR-17-0352. Epub 2017 Nov 13.


Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.

Bai HY, Liao YJ, Cai MY, Ma NF, Zhang Q, Chen JW, Zhang JX, Wang FW, Wang CY, Chen WH, Jin XH, Xu RH, Guan XY, Xie D.

Stem Cells. 2018 Feb;36(2):180-191. doi: 10.1002/stem.2734. Epub 2017 Nov 20.


DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.

Zhou Y, Wang L, Ban X, Zeng T, Zhu Y, Li M, Guan XY, Li Y.

Oncogene. 2018 Feb 22;37(8):1086-1094. doi: 10.1038/onc.2017.383. Epub 2017 Nov 6.


Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancer.

Li L, Zeng TT, Zhang BZ, Li Y, Zhu YH, Guan XY.

Cancer Biol Ther. 2017 Nov 2;18(11):904-915. doi: 10.1080/15384047.2017.1385678. Epub 2017 Oct 20.


FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinoma.

Cao TT, Xiang D, Liu BL, Huang TX, Tan BB, Zeng CM, Wang ZY, Ming XY, Zhang LY, Jin G, Li F, Wu JL, Guan XY, Lu D, Fu L.

Oncotarget. 2017 Jul 26;8(39):65957-65968. doi: 10.18632/oncotarget.19586. eCollection 2017 Sep 12.


Aberrant DNA-PKcs and ERGIC1 expression may be involved in initiation of gastric cancer.

Wang FR, Wei YC, Han ZJ, He WT, Guan XY, Chen H, Li YM.

World J Gastroenterol. 2017 Sep 7;23(33):6119-6127. doi: 10.3748/wjg.v23.i33.6119.


ANGPTL1 Interacts with Integrin α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.

Yan Q, Jiang L, Liu M, Yu D, Zhang Y, Li Y, Fang S, Li Y, Zhu YH, Yuan YF, Guan XY.

Cancer Res. 2017 Nov 1;77(21):5831-5845. doi: 10.1158/0008-5472.CAN-17-0579. Epub 2017 Sep 13.


FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk.

Lau MC, Ng KY, Wong TL, Tong M, Lee TK, Ming XY, Law S, Lee NP, Cheung AL, Qin YR, Chan KW, Ning W, Guan XY, Ma S.

Cancer Res. 2017 Nov 1;77(21):5886-5899. doi: 10.1158/0008-5472.CAN-17-1411. Epub 2017 Sep 7.


TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma.

Ng KY, Chan LH, Chai S, Tong M, Guan XY, Lee NP, Yuan Y, Xie D, Lee TK, Dusetti NJ, Carrier A, Ma S.

Cancer Res. 2017 Sep 1;77(17):4602-4612. doi: 10.1158/0008-5472.CAN-16-3456. Epub 2017 Jul 3.


Calcium-binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracellular signal-regulated kinase signaling pathway.

Jiang L, Yan Q, Fang S, Liu M, Li Y, Yuan YF, Li Y, Zhu Y, Qi J, Yang X, Kwong DLW, Guan XY.

Hepatology. 2017 Nov;66(5):1529-1545. doi: 10.1002/hep.29312. Epub 2017 Sep 29.


Identification of chemokine CXCL10 in tumor microenvironment by antibody array as a prognostic marker in hepatocellular carcinoma.

Li L, Zhu YH, Li Y, Guan XY.

Neoplasma. 2017;64(5):778-786. doi: 10.4149/neo_2017_517.


RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer.

Fu L, Qin YR, Ming XY, Zuo XB, Diao YW, Zhang LY, Ai J, Liu BL, Huang TX, Cao TT, Tan BB, Xiang D, Zeng CM, Gong J, Zhang Q, Dong SS, Chen J, Liu H, Wu JL, Qi RZ, Xie D, Wang LD, Guan XY.

Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4631-E4640. doi: 10.1073/pnas.1703178114. Epub 2017 May 22.


Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma.

Zhang B, Li M, Huang P, Guan XY, Zhu YH.

Thorac Cancer. 2017 Jul;8(4):344-349. doi: 10.1111/1759-7714.12453. Epub 2017 May 16.


Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.

Li B, Xu WW, Lam AKY, Wang Y, Hu HF, Guan XY, Qin YR, Saremi N, Tsao SW, He QY, Cheung ALM.

Oncotarget. 2017 Jun 13;8(24):38755-38766. doi: 10.18632/oncotarget.16333.


Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.

Tian B, Chen X, Zhang H, Li X, Wang J, Han W, Zhang LY, Fu L, Li Y, Nie C, Zhao Y, Tan X, Wang H, Guan XY, Hong A.

Oncotarget. 2017 Jun 27;8(26):42300-42313. doi: 10.18632/oncotarget.15857.


MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF.

Li B, Xu WW, Han L, Chan KT, Tsao SW, Lee NPY, Law S, Xu LY, Li EM, Chan KW, Qin YR, Guan XY, He QY, Cheung ALM.

Oncogene. 2017 Jul 13;36(28):3986-4000. doi: 10.1038/onc.2017.29. Epub 2017 Mar 13.


Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.

Tang PM, Zhou S, Meng XM, Wang QM, Li CJ, Lian GY, Huang XR, Tang YJ, Guan XY, Yan BP, To KF, Lan HY.

Nat Commun. 2017 Mar 6;8:14677. doi: 10.1038/ncomms14677.


Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.

Xu WW, Li B, Guan XY, Chung SK, Wang Y, Yip YL, Law SY, Chan KT, Lee NP, Chan KW, Xu LY, Li EM, Tsao SW, He QY, Cheung AL.

Nat Commun. 2017 Feb 10;8:14399. doi: 10.1038/ncomms14399.


Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma.

Liu DN, Lv A, Tian ZH, Tian XY, Guan XY, Dong B, Zhao M, Hao CY.

Oncotarget. 2017 Jan 31;8(5):7766-7776. doi: 10.18632/oncotarget.13950.


Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma.

Ming XY, Fu L, Zhang LY, Qin YR, Cao TT, Chan KW, Ma S, Xie D, Guan XY.

Nat Commun. 2016 Dec 7;7:13568. doi: 10.1038/ncomms13568.


Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.

Cao TT, Lin SH, Fu L, Tang Z, Che CM, Zhang LY, Ming XY, Liu TF, Tang XM, Tan BB, Xiang D, Li F, Chan OY, Xie D, Cai Z, Guan XY.

Carcinogenesis. 2017 Jan;38(1):94-104. doi: 10.1093/carcin/bgw119. Epub 2016 Nov 22.


The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery.

Stunnenberg HG; International Human Epigenome Consortium, Hirst M.

Cell. 2016 Nov 17;167(5):1145-1149. doi: 10.1016/j.cell.2016.11.007. Erratum in: Cell. 2016 Dec 15;167(7):1897.


Octamer 4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells.

Chai S, Ng KY, Tong M, Lau EY, Lee TK, Chan KW, Yuan YF, Cheung TT, Cheung ST, Wang XQ, Wong N, Lo CM, Man K, Guan XY, Ma S.

Hepatology. 2016 Dec;64(6):2062-2076. doi: 10.1002/hep.28821. Epub 2016 Oct 27.


SEI1 induces genomic instability by inhibiting DNA damage response in ovarian cancer.

You J, Liu J, Bao Y, Wang L, Yu Y, Wang L, Wu D, Liu C, Wang N, Wang F, Wang F, Xu L, Tian X, Liang H, Gao Y, Guan R, Bai J, Meng X, Sun W, Guan XY, Zhang C, Fu S, Jin Y.

Cancer Lett. 2017 Jan 28;385:271-279. doi: 10.1016/j.canlet.2016.09.032. Epub 2016 Oct 3.


TLR4 polymorphism and periodontitis susceptibility: A meta-analysis.

Jin SH, Guan XY, Liang WH, Bai GH, Liu JG.

Medicine (Baltimore). 2016 Sep;95(36):e4845. doi: 10.1097/MD.0000000000004845. Review.


Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.

Huang PY, Zeng TT, Ban X, Li MQ, Zhang BZ, Zhu YH, Hua WF, Mai HQ, Zhang L, Guan XY, Li Y.

BMC Cancer. 2016 Aug 22;16:669. doi: 10.1186/s12885-016-2714-2.


Met promotes the formation of double minute chromosomes induced by Sei-1 in NIH-3T3 murine fibroblasts.

Bao Y, Liu J, You J, Wu D, Yu Y, Liu C, Wang L, Wang F, Xu L, Wang L, Wang N, Tian X, Wang F, Liang H, Gao Y, Cui X, Ji G, Bai J, Yu J, Meng X, Jin Y, Sun W, Guan XY, Zhang C, Fu S.

Oncotarget. 2016 Aug 30;7(35):56664-56675. doi: 10.18632/oncotarget.10994.


CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.

Li CP, Cai MY, Jiang LJ, Mai SJ, Chen JW, Wang FW, Liao YJ, Chen WH, Jin XH, Pei XQ, Guan XY, Zeng MS, Xie D.

Carcinogenesis. 2016 Jun;37(6):557-566. doi: 10.1093/carcin/bgw036. Epub 2016 Mar 31.


Corrigendum to "Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma" [J Hepatol 2015;62:607-616].

Yeung OW, Lo CM, Ling CC, Qi X, Geng W, Li CX, Ng KT, Forbes SJ, Guan XY, Poon RT, Fan ST, Man K.

J Hepatol. 2016 Jun;64(6):1461. doi: 10.1016/j.jhep.2016.02.038. Epub 2016 Mar 16. No abstract available.


Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B.

Li XD, Zhang JX, Jiang LJ, Wang FW, Liu LL, Liao YJ, Jin XH, Chen WH, Chen X, Guo SJ, Zhou FJ, Zeng YX, Guan XY, Liu ZW, Xie D.

Oncogene. 2016 Dec 8;35(49):6281-6292. doi: 10.1038/onc.2016.165. Epub 2016 May 16.


CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.

Liu M, Chen L, Ma NF, Chow RK, Li Y, Song Y, Chan TH, Fang S, Yang X, Xi S, Jiang L, Li Y, Zeng TT, Li Y, Yuan YF, Guan XY.

Hepatology. 2016 May;63(5):1544-59. doi: 10.1002/hep.28437. Epub 2016 Mar 4.


Neuropilin-2 promotes tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK-MAPK-ETV4-MMP-E-cadherin deregulation.

Fung TM, Ng KY, Tong M, Chen JN, Chai S, Chan KT, Law S, Lee NP, Choi MY, Li B, Cheung AL, Tsao SW, Qin YR, Guan XY, Chan KW, Ma S.

J Pathol. 2016 Jul;239(3):309-19. doi: 10.1002/path.4728. Epub 2016 May 5.


C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.

Ng KY, Chai S, Tong M, Guan XY, Lin CH, Ching YP, Xie D, Cheng AS, Ma S.

Oncotarget. 2016 Apr 26;7(17):24005-17. doi: 10.18632/oncotarget.8209.


Characterization of oncogene-induced metabolic alterations in hepatic cells by using ultrahigh performance liquid chromatography-tandem mass spectrometry.

Tang Z, Cao T, Lin S, Fu L, Li S, Guan XY, Cai Z.

Talanta. 2016 May 15;152:119-26. doi: 10.1016/j.talanta.2016.01.056. Epub 2016 Jan 28.


Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133 under low glucose conditions.

Lin SH, Liu T, Ming X, Tang Z, Fu L, Schmitt-Kopplin P, Kanawati B, Guan XY, Cai Z.

Sci Rep. 2016 Feb 16;6:21184. doi: 10.1038/srep21184.


PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinoma.

Zhang LY, Wu JL, Qiu HB, Dong SS, Zhu YH, Lee VH, Qin YR, Li Y, Chen J, Liu HB, Bi J, Ma S, Guan XY, Fu L.

Carcinogenesis. 2016 Mar;37(3):320-332. doi: 10.1093/carcin/bgw010. Epub 2016 Jan 19.


CD68 and interleukin 13, prospective immune markers for esophageal squamous cell carcinoma prognosis prediction.

Li J, Zhang BZ, Qin YR, Bi J, Liu HB, Li Y, Cai MY, Ma S, Chan KW, Xie D, Guan XY.

Oncotarget. 2016 Mar 29;7(13):15525-38. doi: 10.18632/oncotarget.6900.


CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy.

Li J, Chen JN, Zeng TT, He F, Chen SP, Ma S, Bi J, Zhu XF, Guan XY.

BMC Cancer. 2016 Jan 13;16:15. doi: 10.1186/s12885-016-2050-6.


CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.

Yang J, Lv X, Chen J, Xie C, Xia W, Jiang C, Zeng T, Ye Y, Ke L, Yu Y, Liang H, Guan XY, Guo X, Xiang Y.

Oncotarget. 2016 Mar 29;7(13):15632-47. doi: 10.18632/oncotarget.6695.


Nanoporous TiO2-Based Distributed Bragg Reflectors for Near-Infrared Wavelength Applications.

Guan XY, Leem JW, Yu JS.

J Nanosci Nanotechnol. 2015 Dec;15(12):9650-5.


bFGF binding cardiac extracellular matrix promotes the repair potential of bone marrow mesenchymal stem cells in a rabbit model for acute myocardial infarction.

Zhang GW, Gu TX, Guan XY, Sun XJ, Qi X, Li XY, Wang XB, Yu L, Jiang DQ, Tang R, Li-Ling J.

Biomed Mater. 2015 Dec 14;10(6):065018. doi: 10.1088/1748-6041/10/6/065018.


Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.

Li J, Li B, Xu WW, Chan KW, Guan XY, Qin YR, Lee NP, Chan KT, Law S, Tsao SW, Cheung AL.

Expert Opin Ther Targets. 2016;20(1):7-18. doi: 10.1517/14728222.2016.1121236. Epub 2015 Dec 15.


Prognostic significance of FAM3C in esophageal squamous cell carcinoma.

Zhu YH, Zhang B, Li M, Huang P, Sun J, Fu J, Guan XY.

Diagn Pathol. 2015 Oct 24;10:192. doi: 10.1186/s13000-015-0424-8.


Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.

Li B, Xu WW, Guan XY, Qin YR, Law S, Lee NP, Chan KT, Tam PY, Li YY, Chan KW, Yuen HF, Tsao SW, He QY, Cheung AL.

Clin Cancer Res. 2016 Mar 1;22(5):1243-55. doi: 10.1158/1078-0432.CCR-15-1196. Epub 2015 Oct 16.


HGF and IGF-1 promote protective effects of allogeneic BMSC transplantation in rabbit model of acute myocardial infarction.

Zhang GW, Gu TX, Guan XY, Sun XJ, Qi X, Li XY, Wang XB, Lv F, Yu L, Jiang DQ, Tang R.

Cell Prolif. 2015 Dec;48(6):661-70. doi: 10.1111/cpr.12219. Epub 2015 Oct 15.


Decreased expression of H3K27me3 in human ovarian carcinomas correlates with more aggressive tumor behavior and poor patient survival.

He WP, Li Q, Zhou J, H ZS, Kung HF, Guan XY, Xie D, Yang GF.

Neoplasma. 2015;62(6):932-7. doi: 10.4149/neo_2015_113.


Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.

He LR, Ma NF, Chen JW, Li BK, Guan XY, Liu MZ, Xie D.

Oncotarget. 2015 Oct 13;6(31):31181-90. doi: 10.18632/oncotarget.5070.

Supplemental Content

Loading ...
Support Center